title: Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays.
abstract: OBJECTIVE
  Intraoperative radiotherapy (IORT) of the tumor bed in early breast cancer is presently performed with a single dose of 50-kV X-rays from a miniaturized X-ray machine using spherical applicators. The purpose was to model the biological effect of hypofractionated accelerated partial-breast irradiation (APBI) with ten fractions.
  
  
  METHODS
  The relative biologic effectiveness (RBE) was estimated from the linear-quadratic (L-Q) formalism including repair of sublethal damage or assuming a constant RBE = 1.2-1.5. The radial distribution of biological effect was assessed from clinical dose-response curves. In accordance with clinical convention, the dose for APBI was prescribed at 1 cm depth in the tumor bed, whereas for IORT it was prescribed at the applicator surface.
  
  
  RESULTS
  The fraction size was fitted to give the same risk of late normal-tissue reaction (fibrosis) as single-dose IORT with a maximum dose of 20 Gy. The isoeffective fraction size at 1 cm depth varied between 1.01 Gy for RBE estimated from the L-Q model and 1.64 Gy for constant RBE. The applicator size and dose prescription point influenced the radial dose distribution. The "sphere of equivalence" within which the risk for local recurrence is the same for whole-breast radiotherapy was predicted to extend to 11-15 mm distance from the applicator for alpha/beta = 10 Gy and 9-13 mm for alpha/beta = 4 Gy for hypofractionated APBI, representing an increase of the sphere of equivalence by 2.5-6 mm relative to single-dose IORT.
  
  
  CONCLUSIONS
  An increase of the therapeutic window with hypofractionated APBI relative to single-dose IORT should be feasible.
authors.affiliation: Department of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany. carsten.herskind@medma.uni-heidelberg.de
authors.forename: Carsten
authors.initials: C
authors.lastname: Herskind
authors.forename: Frederik
authors.initials: F
authors.lastname: Wenz
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D001940:Breast / Q000528:radiation effects; D001943:Breast Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D004867:Equipment Design; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy; D008954:Models, Biological; D017564:Radiation Pneumonitis / Q000209:etiology / Q000517:prevention & control; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D012062:Relative Biological Effectiveness
references.citation: Curr Oncol Rep. 2008 Jan;10(1):54-60
references.pmid: 18366961
references.citation: Surgery. 2006 Sep;140(3):467-71
references.pmid: 16934611
references.citation: Radiother Oncol. 1989 Jul;15(3):267-74
references.pmid: 2772254
references.citation: Radiother Oncol. 2010 Mar;94(3):388-9; author reply 390
references.pmid: 19853317
references.citation: Int J Radiat Oncol Biol Phys. 1981 Apr;7(4):461-7
references.pmid: 7251416
references.citation: Strahlenther Onkol. 2009 Jul;185(7):431-7
references.pmid: 19714304
references.citation: Int J Radiat Oncol Biol Phys. 1985 Jan;11(1):87-96
references.pmid: 3881377
references.citation: Breast Cancer. 2009;16(2):105-12
references.pmid: 18807124
references.citation: J Clin Oncol. 2003 Feb 1;21(3):555-63
references.pmid: 12560449
references.citation: Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):694-702
references.pmid: 17531400
references.citation: Nat Clin Pract Oncol. 2007 Jul;4(7):384-5
references.pmid: 17549089
references.citation: Strahlenther Onkol. 2010 Feb;186(2):113-114
references.pmid: 20127229
references.citation: Ann Surg. 2005 Jul;242(1):101-6
references.pmid: 15973107
references.citation: Brachytherapy. 2009 Oct-Dec;8(4):373-8
references.pmid: 19736045
references.citation: Strahlenther Onkol. 2006 Oct;182(10):589-95
references.pmid: 17013572
references.citation: Strahlenther Onkol. 2009 Oct;185(10):653-5
references.pmid: 19806329
references.citation: Int J Radiat Biol. 2000 Apr;76(4):447-52
references.pmid: 10815623
references.citation: Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1575-81
references.pmid: 19028280
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):987-1001
references.pmid: 19545784
references.citation: Radiother Oncol. 2005 Apr;75(1):6-8
references.pmid: 15878094
references.citation: Int J Cancer. 2006 Jun 1;118(11):2882-7
references.pmid: 16381011
references.citation: Lancet Oncol. 2008 Apr;9(4):331-41
references.pmid: 18356109
references.citation: Acta Oncol. 1988;27(2):105-16
references.pmid: 3390341
references.citation: Strahlenther Onkol. 2008 Jun;184(6):307-12
references.pmid: 18535806
references.citation: Radiat Res. 2005 Feb;163(2):208-15
references.pmid: 15658897
references.citation: Radiother Oncol. 2008 Apr;87(1):3-16
references.pmid: 18160158
references.citation: Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):377-81
references.pmid: 16887294
references.citation: Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1120-7
references.pmid: 19910132
references.citation: Phys Med Biol. 1999 Feb;44(2):323-33
references.pmid: 10070784
references.citation: Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1335-8
references.pmid: 17084562
references.citation: Strahlenther Onkol. 2009 Mar;185(3):170-6
references.pmid: 19330294
references.citation: J Cancer Res Ther. 2009 Apr-Jun;5(2):93-101
references.pmid: 19542664
references.citation: Breast. 2008 Dec;17(6):617-22
references.pmid: 18650091
references.citation: Radiother Oncol. 2009 Apr;91(1):16-22
references.pmid: 19178972
references.citation: Am J Surg. 2009 Jul;198(1):83-91
references.pmid: 19268900
references.citation: Lancet Oncol. 2004 Mar;5(3):165-73
references.pmid: 15003199